Cash Flow

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Oct. 31, 2017
Oct. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (130,829) $ (4,640)
Loss from discontinued operations 349 807
Loss from continuing operations (130,480) (3,833)
Adjustments to reconcile net loss from continuing operations to net cash used in continuing operating activities:    
Depreciation and amortization 432
Stock based compensation expense 16,627 2,042
Research and development - intellectual property acquired 104,693
Change in fair value of derivatives (109) (248)
Offering costs expensed 21
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (190) 54
Accounts payable and accrued expenses 1,411 85
Net cash used in continuing operating activities (7,616) (1,879)
Net cash provided by discontinued operating activities 33 113
Net cash used in operating activities (7,583) (1,766)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of property and equipment (2,544)
Net cash used in continuing investing activities (2,544)
Net cash provided by discontinued investing activities 25
Net cash used in investing activities (2,519)
CASH FLOWS FROM FINANCING ACTIVITIES    
Special cash dividend (10,000)
Proceeds from stock options exercised 1,301 129
Net proceeds from the sale of preferred stock and warrants 17,667
Net proceeds from the sale of common stock and warrants 1,406
Proceeds from the sale of common stock 2,278
Payments to Zift (299)
Net cash provided by (used in) financing activities 21,246 (8,764)
Net increase (decrease) in cash and cash equivalents 11,144 (10,530)
Cash and cash equivalents - beginning of period 6,523 17,053
Cash and cash equivalents - end of period 17,667 6,523
Supplemental schedule of non-cash investing and financing activities:    
Conversion of Series A preferred stock to common stock 976 401
Conversion of Series B preferred stock to common stock 549
Conversion of Series C preferred stock to common stock 1,809
Conversion of Series D preferred stock to common stock 1,517 140
Warrants exchanged for common stock shares 78
Establishment of warrant liability in connection with Series F Preferred Stock issuance 4,299
Establishment of derivative liability in connection with Series F Preferred Stock issuance 9,319
Deemed dividend - accretion of discount on Series F preferred stock 369
Common stock shares and warrants issued for offering costs 75
Unpaid liability for acquisition of property and equipment 54
Cumulative dividends on Series F preferred stock $ 124

Source